The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist
Open accessAbstract
Background Tuberous sclerosis complex is a multisystem genetic disorder with a range of physical manifestations that require evaluation, surveillance, and management. Individuals with tuberous sclerosis complex also have a range of behavioral, psychiatric, intellectual, academic, neuropsychologic, and psychosocial difficulties. These may represent the greatest burden of the disease. Around 90% of individuals with tuberous sclerosis complex will have some of these difficulties during their lifetime, yet only about 20% ever receive evaluation and treatment. The Neuropsychiatry Panel at the 2012 Tuberous Sclerosis Complex International Consensus Conference expressed concern about the significant "treatment gap" and about confusion regarding terminology relating to the biopsychosocial difficulties associated with tuberous sclerosis complex. Methods The Tuberous Sclerosis Complex Neuropsychiatry Panel coined the term TAND-tuberous sclerosis complex-associated neuropsychiatric disorders-to bring together these multidimensional manifestations of the disorder, and recommended annual screening for TAND. In addition, the Panel agreed to develop a TAND Checklist as a guide for screening. Results Here, we present an outline of the conceptualization of TAND, rationale for the structure of the TAND Checklist, and include the full US English version of the TAND Checklist. Conclusion We hope that the unified term TAND and the TAND Checklist will raise awareness of the importance of tuberous sclerosis complex-associated neuropsychiatric disorders and of the major burden of disease associated with it, provide a shared language and a simple tool to describe and evaluate the different levels of TAND, alert clinical teams and families or individuals of the importance of screening, assessment, and treatment of TAND, and provide a shared framework for future studies of tuberous sclerosis complex-associated neuropsychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Development of the TAND checklist was necessary because 90% of patients with TSC endorsed neuropsychiatric symptoms, yet only 20% received treatment.11”
From Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia (2020) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Individuals with TSC commonly experience a wide spectrum of cognitive, behavioral and psychiatric symptoms collectively known as Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND) (5).”
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the physical manifestations of TSC, these patients frequently suffer from behavioral, cognitive and psychiatric difficulties collectively termed Tuberous Sclerosis Complex Associated Neuropsychiatric disorders (TAND) [14].”
From Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation (2022) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“The TAND checklist serves as a clinical screening tool to assess neuropsychiatric difficulties that include the behavioral, cognitive and psychiatric domains.11”
From Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia (2020) · cites this paper as [11]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Generally, prior reports depict tau-related changes as elevated p-tau staining in the absence of frank neurofibrillary tangles.”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“TSC tauopathy also differs from other TSC-related tau abnormalities previously reported in the TSC literature by our group [12, 16] and others [6, 11].”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Goodman, R. (1999) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00494 · Cited by 1,760
Northrup, H., Krueger, D. A., Northrup, H., Krueger, D. A., Roberds, S., Smith, K., Sampson, J., Korf, B., Kwiatkowski, D. J., Mowat, D., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.001 · Cited by 1,502
Self-citationAutism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464
Curatolo, P., Bombardieri, R., & Jóźwiak, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61279-9 · Cited by 1,106
Bissler, J. J., Kingswood, J. C., Radzikowska, E., Zonnenberg, B. A., Frost, M., Белоусова, Е. Д., Sauter, M., Nonomura, N., Brakemeier, S., de Vries, P. J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61767-x · Cited by 880
Self-citationKrueger, D. A., Northrup, H., Northrup, H., Krueger, D. A., Roberds, S. L., Smith, K., Sampson, J. R., Korf, B. R., Kwiatkowski, D. J., Mowat, D. R., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.002 · Cited by 851
Self-citationFranz, D. N., Belousova, E., Sparagana, S., Bebin, E. M., Frost, M., Kuperman, R., Witt, O., Kohrman, M. H., Flamini, J. R., Wu, J. Y., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61134-9 · Cited by 794
Self-citation
Cited by
Sorted by citations
Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 886
Northrup, H., Aronow, M. E., Bebin, E. M., Bissler, J. J., Darling, T. N., de Vries, P. J., Frost, M., Fuchs, Z., Gosnell, E. S., Gupta, N., et al. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.07.011 · Cited by 770
Self-citationNeurological and neuropsychiatric aspects of tuberous sclerosis complex
Curatolo, P., Moavero, R., & de Vries, P. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00069-1 · Cited by 600
Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
Nabbout, R., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., Dahlin, M. G., ́Amato, L. D., d’Augères, G. B., de Vries, P. J., et al. (2018) · Epilepsia Open · doi:10.1002/epi4.12286 · Cited by 249
Self-citationCannabinoids in treatment-resistant epilepsy: A review
O’Connell, B. K., Gloss, D. S., & Devinsky, O. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.012 · Cited by 228
Tuberous Sclerosis Complex: A Review
Randle, S. C. (2017) · Pediatric Annals · doi:10.3928/19382359-20170320-01 · Cited by 203
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
Curatolo, P., Nabbout, R., Lagae, L., Aronica, E., Ferreira, J. C., Feucht, M., Hertzberg, C., Jansen, A. C., Jansen, F., Kotulska, K., et al. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.05.006 · Cited by 190
Self-citationTSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study
de Vries, P. J., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., Dahlin, M. G., D’Amato, L., d’Augères, G. B., Ferreira, J. C., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0901-8 · Cited by 190
Self-citationEbrahimi‐Fakhari, D., & Şahin, M. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000186 · Cited by 177
Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
Salussolia, C. L., Klonowska, K., Kwiatkowski, D. J., & Sahin, M. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015354 · Cited by 163
Pilot Validation of the Tuberous Sclerosis-Associated Neuropsychiatric Disorders (TAND) Checklist
Leclezio, L., Jansen, A., Whittemore, V., & de Vries, P. J. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.10.006 · Cited by 158
Self-citationEverolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
Krueger, D. A., Sadhwani, A., Byars, A. W., de Vries, P. J., Franz, D. N., Whittemore, V. H., Filip‐Dhima, R., Murray, D., Kapur, K., & Sahin, M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.494 · Cited by 133
Self-citationRenal disease in tuberous sclerosis complex: pathogenesis and therapy
Lam, H. C., Siroky, B. J., & Henske, E. P. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0059-6 · Cited by 135
A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)
Zöllner, J. P., Franz, D. N., Hertzberg, C., Nabbout, R., Rosenow, F., Sauter, M., Schubert‐Bast, S., Wiemer‐Kruel, A., & Strzelczyk, A. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1258-3 · Cited by 130
Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants
Davis, P. E., Filip‐Dhima, R., Sideridis, G. D., Peters, J. M., Au, K. S., Northrup, H., Bebin, E. M., Wu, J. Y., Krueger, D. A., & Şahin, M. (2017) · PEDIATRICS · doi:10.1542/peds.2016-4040 · Cited by 129
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex
Curatolo, P., Moavero, R., Roberto, D., & Graziola, F. (2015) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2015.10.002 · Cited by 128
Giannikou, K., Malinowska, I. A., Pugh, T. J., Yan, R., Tseng, Y., Oh, C., Kim, J., Tyburczy, M. E., Chekaluk, Y. I., Liu, Y., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006242 · Cited by 128
Epilepsy in the mTORopathies: opportunities for precision medicine
Moloney, P. B., Cavalleri, G. L., & Delanty, N. (2021) · Brain Communications · doi:10.1093/braincomms/fcab222 · Cited by 125
A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND)
de Vries, P. J., Wilde, L., de Vries, M. C., Moavero, R., Pearson, D. A., & Curatolo, P. (2018) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31637 · Cited by 126
mTOR, a Potential Target to Treat Autism Spectrum Disorder
Sato, A. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120638 · Cited by 117
Symptom profiles of autism spectrum disorder in tuberous sclerosis complex
Jeste, S., Varcin, K. J., Hellemann, G., Gulsrud, A. C., Bhatt, R. R., Kasari, C. L., Wu, J. Y., Şahin, M., & Nelson, C. A. (2016) · Neurology · doi:10.1212/wnl.0000000000003002 · Cited by 118
Kosillo, P., & Bateup, H. S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.700968 · Cited by 112
Kingswood, J. C., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., Dahlin, M. G., ́Amato, L. D., d’Augères, G. B., de Vries, P. J., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy063 · Cited by 109
Self-citationTuberous sclerosis: a review of the past, present, and future
Uysal, S. P., & Şahin, M. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2002-133 · Cited by 108
The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models
Mapelli, L., Soda, T., D'Angelo, E. U., & Prestori, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073894 · Cited by 114
Physical health in children with neurodevelopmental disorders
Alabaf, S., Gillberg, C., Lundström, S., Lichtenstein, P., Kerekes, N., Råstam, M., & Anckarsäter, H. S. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-018-3697-4 · Cited by 103
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Luo, C., Ye, W.-R., Shi, W., Yin, P., Chen, C., He, Y., Chen, M., Zu, X., & Cai, Y. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02266-0 · Cited by 99
Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers
Vignoli, A., Briola, F. L., Peron, A., Turner, K., Vannicola, C., Saccani, M., Magnaghi, E., Scornavacca, G. F., & Canevini, M. P. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0371-1 · Cited by 91
Islam, M. P., & Roach, E. S. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62702-5.00006-8 · Cited by 89
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
Specchio, N., Pietrafusa, N., Trivisano, M., Moavero, R., Palma, L. D., Ferretti, A., Vigevano, F., & Curatolo, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00639 · Cited by 78
Tsc1-mTORC1 signaling controls striatal dopamine release and cognitive flexibility
Kosillo, P., Doig, N. M., Ahmed, K. M., Agopyan-Miu, A. H. C. W., Wong, C. D., Conyers, L., Threlfell, S., Magill, P. J., & Bateup, H. S. (2019) · Nature Communications · doi:10.1038/s41467-019-13396-8 · Cited by 74
Krueger, D. A., Capal, J. K., Curatolo, P., Devinsky, O., Ess, K. C., Tzadok, M., Koenig, M. K., Narayanan, V., Ramos, F. J., Jóźwiak, S., et al. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.06.007 · Cited by 73
Self-citationWorries and needs of adults and parents of adults with neurofibromatosis type 1
Rietman, A. B., van Helden, H., Both, P. H., Taal, W., Legerstee, J. S., van Staa, A., Moll, H. A., Oostenbrink, R., & van Eeghen, A. M. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38680 · Cited by 72
Cortical wiring by synapse type–specific control of local protein synthesis
Bernard, C., Exposito-Alonso, D., Selten, M., Sanalidou, S., Hanusz-Godoy, A., Aguilera, A., Hamid, F., Oozeer, F., Maeso, P., Allison, L., et al. (2022) · Science · doi:10.1126/science.abm7466 · Cited by 81
Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments
Sampson, J. R., & Saxena, A. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552616 · Cited by 65
Auvin, S., Bissler, J. J., Cottin, V., Fujimoto, A., Hofbauer, G. F. L., Jansen, A., Jóźwiak, S., Kerecuk, L., Kingswood, J. C., Moavero, R., et al. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1072-y · Cited by 65
Self-citationEpilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
Gupta, A., de Bruyn, G., Tousseyn, S., Krishnan, B., Lagae, L., Agarwal, N., Minnesota Epilepsy Group, Frost, M., Sparagana, S., LaJoie, J., et al. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.12.016 · Cited by 64
Self-citationApplying the Lessons of Tuberous Sclerosis: The 2015 Hower Award Lecture
Roach, E. S. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.07.003 · Cited by 60
Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role
Cardis, M. A., & DeKlotz, C. M. C. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-312001 · Cited by 59
Fohlen, M., Taussig, D., Ferrand‐Sorbets, S., Chipaux, M., Dorison, N., Delalande, O., & Dorfmüller, G. (2018) · Seizure · doi:10.1016/j.seizure.2018.06.005 · Cited by 59
Hasbani, D. M., & Crino, P. B. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00052-1 · Cited by 58
Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism
Davis, P. E., Peters, J. M., Krueger, D. A., & Şahin, M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0359-5 · Cited by 58
de Vries, P. J., Heunis, T.-M., Vanclooster, S., Chambers, N. J., Bissell, S., Byars, A. W., Flinn, J., Gipson, T., van Eeghen, A. M., Waltereit, R., et al. (2023) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-023-09500-1 · Cited by 57
Self-citationAlquezar, C., Schoch, K. M., Geier, E. G., Ramos, E. M., Scrivo, A., Li, K. H., Argouarch, A. R., Mlynarski, E. E., Dombroski, B., DeTure, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3897 · Cited by 56
van Andel, D. M., Sprengers, J. J., Oranje, B., Scheepers, F. E., Jansen, F. E., & Bruining, H. (2020) · Molecular Autism · doi:10.1186/s13229-020-00335-4 · Cited by 55
Islam, M. P. (2021) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2021.100875 · Cited by 55
Şahin, M., Henske, E. P., Manning, B. D., Ess, K. C., Bissler, J. J., Klann, E., Kwiatkowski, D. J., Roberds, S. L., Silva, A. J., Hillaire‐Clarke, C. S., et al. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.03.015 · Cited by 57
Self-citationSchubert‐Bast, S., & Strzelczyk, A. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211031100 · Cited by 50
Advances in the treatment of tuberous sclerosis complex
Leclezio, L., & de Vries, P. J. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000136 · Cited by 51
Self-citationBar, C., Ghobeira, R., Azzi, R., Ville, D., Riquet, A., Touraine, R., Chemaly, N., & Nabbout, R. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.027 · Cited by 49
Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children
Park, S., Lee, E. J., Eom, S., Kang, H., Lee, J. S., & Kim, H. D. (2017) · Journal of Epilepsy Research · doi:10.14581/jer.17008 · Cited by 49
Kelly, E., Schaeffer, S. M., Dhamne, S. C., Lipton, J. O., Lindemann, L., Honer, M., Jaeschke, G., Super, C. E., Lammers, S. H. T., Modi, M. E., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.295 · Cited by 50
Burden of Illness and Quality of Life in Tuberous Sclerosis Complex: Findings From the TOSCA Study
Jansen, A., Vanclooster, S., de Vries, P. J., Fladrowski, C., d’Augères, G. B., Carter, T., Belousova, E., Benedik, M. P., Cottin, V., Curatolo, P., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00904 · Cited by 49
Self-citationZucco, A. J., Pozzo, V. D., Afinogenova, A., Hart, R. P., Devinsky, O., & D’Arcangelo, G. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.08.004 · Cited by 48
Surgery for drug‐resistant tuberous sclerosis complex‐associated epilepsy: who, when, and what
Specchio, N., Pepi, C., Palma, L. D., Moavero, R., BENEDICTIS, A. D., Marras, C. E., Vigevano, F., & Curatolo, P. (2021) · Epileptic Disorders · doi:10.1684/epd.2021.1253 · Cited by 48
Early autism symptoms in infants with tuberous sclerosis complex
McDonald, N. M., Varcin, K. J., Bhatt, R. R., Wu, J. Y., Şahin, M., Nelson, C. A., & Jeste, S. (2017) · Autism Research · doi:10.1002/aur.1846 · Cited by 44
Vanclooster, S., Bissell, S., van Eeghen, A. M., Chambers, N. J., Waele, L. D., Byars, A. W., Capal, J. K., Cukier, S., Davis, P. E., Flinn, J., et al. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09423-3 · Cited by 43
Self-citationHe, W., Chen, J., Wang, Y., Zhang, M., Qian-Lu, Wang, Q., Luo, X., Chen, X.-Q., & Zou, L. (2020) · Seizure · doi:10.1016/j.seizure.2020.03.018 · Cited by 43
Franz, D. N., Lawson, J. A., Yapıcı, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D., Herbst, F., et al. (2021) · Epilepsia · doi:10.1111/epi.17099 · Cited by 43
Tuberous sclerosis‐associated neuropsychiatric disorders: a paediatric cohort study
Toldo, I., Brasson, V., Miscioscia, M., Pelizza, M. F., Manara, R., Sartori, S., Mantegazza, G., Vecchi, M., Nosadini, M., & Gatta, M. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14055 · Cited by 41
Challenges and opportunities for precision medicine in neurodevelopmental disorders
Chen, G. T., & Geschwind, D. H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114564 · Cited by 40
Dickinson, A. H., Varcin, K. J., Şahin, M., Nelson, C. A., & Jeste, S. (2019) · Autism Research · doi:10.1002/aur.2193 · Cited by 41
Precision Therapy for Epilepsy Related to Brain Malformations
D’Gama, A. M., & Poduri, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01122-6 · Cited by 40
Capal, J. K., Williams, M. E., Pearson, D. A., Kissinger, R. D., Horn, P. S., Murray, D. S., Currans, K., Kent, B., Bebin, M., Northrup, H., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26249 · Cited by 41
Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment
Mizuguchi, M., Ohsawa, M., Kashii, H., & Sato, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136677 · Cited by 37
Peron, A., Vignoli, A., Briola, F. L., Morenghi, E., Tansini, L., Alfano, R. M., Bulfamante, G., Terraneo, S., Ghelma, F., Banderali, G., et al. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.02.005 · Cited by 36
de Vries, P. J., Franz, D. N., Curatolo, P., Nabbout, R., Neary, M. P., Herbst, F., Sully, K., Brohan, E., Bennett, B., & Lawson, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00964 · Cited by 34
de Vries, P. J., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., D’Amato, L., d’Augères, G. B., Ferreira, J. C., Feucht, M., et al. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-09327-0 · Cited by 33
Self-citationCapal, J. K., Horn, P. S., Murray, D. S., Byars, A. W., Bing, N. M., Kent, B., Bucher, L. A., Williams, M. E., O’Kelley, S. E., Pearson, D. A., et al. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.06.010 · Cited by 32
Self-citationPetrásek, T., Vojtěchová, I., Klovrza, O., Tuckova, K., Vejmola, Č., Rak, J., Šuláková, A., Kaping, D., Bernhardt, N. R., de Vries, P. J., et al. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09357-2 · Cited by 33
Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
Ding, Y., Wang, J., Zhou, Y., Yu, L., Zhang, L., Zhou, S., & Wang, Y. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13473 · Cited by 31
Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care
Annear, N. M. P., Appleton, R. E., Bassi, Z., Bhatt, R. I., Bolton, P., Crawford, P. M., Crowe, A., Tossi, M., Elmslie, F., Finlay, E., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01116 · Cited by 29
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
Feldman, H., Cummings, J. L., Boxer, A. L., Staffaroni, A. M., Knopman, D. S., Rizzo, S. J. S., Territo, P. R., Arnold, S. E., Ballard, C. G., Beher, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14250 · Cited by 27
Cross-sectional Imaging Review of Tuberous Sclerosis
Krishnan, A. S., Kaza, R. K., & Vummidi, D. R. (2016) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2015.12.003 · Cited by 27
Cervi, F., Saletti, V., Turner, K., Peron, A., Bulgheroni, S., Taddei, M., Briola, F. L., Canevini, M. P., & Vignoli, A. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01488-4 · Cited by 24
Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus
Previtali, R., Prontera, G., Alfei, E., Nespoli, L. F., Masnada, S., Veggiotti, P., & Mannarino, S. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106884 · Cited by 24
de Vries, P. J., Leclezio, L., Gardner‐Lubbe, S., Krueger, D. A., Şahin, M., Sparagana, S. P., Waele, L. D., & Jansen, A. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02076-w · Cited by 23
Self-citationEbrahimi‐Fakhari, D., Hussong, J., Flotats‐Bastardas, M., Ebrahimi‐Fakhari, D., Zemlin, M., von Gontard, A., & Meyer, S. (2019) · Neuropediatrics · doi:10.1055/s-0039-1693042 · Cited by 22
Heunis, T.-M., Chambers, N. J., Vanclooster, S., Bissell, S., Byars, A. W., Capal, J. K., Cukier, S., Davis, P. E., de Vries, M. C., Waele, L. D., et al. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.07.001 · Cited by 22
Self-citationManifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic
Wilbur, C., Sanguansermsri, C., Chable, H., Anghelina, M., Peinhof, S., Anderson, K., Steinbok, P., Singhal, A., Datta, A., & Connolly, M. B. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.311 · Cited by 22
Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives
Wan, M. J., Chan, K. L., Jastrzembski, B. G., & Ali, A. (2019) · Eye and Brain · doi:10.2147/eb.s186306 · Cited by 22
Scoping review of symptoms in children with rare, progressive, life-threatening disorders
Pawliuk, C., Widger, K., Dewan, T., Brander, G., Brown, H. L., Hermansen, A., Grégoire, M.-C., Steele, R., & Siden, H. B. (2019) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2019-001943 · Cited by 22
Randell, E., McNamara, R. L., Davies, D. M., Owen-Jones, E., Kirby, N., Angel, L., Drew, C., Cannings-John, R. L., Smalley, M., Saxena, A., et al. (2016) · Trials · doi:10.1186/s13063-016-1446-6 · Cited by 21
Quality of life of children with tuberous sclerosis complex
Fong, C. Y., Ng, K., Kong, A. N., Ong, L. C., Mohamed, A. R., Thong, M., Ganesan, V. M., Heng, H. S., Teh, C. M., & Yahya, N. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316394 · Cited by 21
Frudit, P., Vitturi, B. K., Navarro, F. C., Rondelli, I., & Pozzan, G. (2019) · Autopsy and Case Reports · doi:10.4322/acr.2019.125 · Cited by 21
Shaffer, R. C., Reisinger, D. L., Schmitt, L., Lamy, M., Dominick, K. C., Smith, E. G., Coffman, M. C., & Esbensen, A. J. (2022) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2022.06.020 · Cited by 22
Heunis, T.-M., Bissell, S., Byars, A. W., Capal, J. K., Chambers, N. J., Cukier, S., Davis, P. E., Waele, L. D., Flinn, J., Gardner‐Lubbe, S., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.834628 · Cited by 20
Self-citationFranz, D. N., & Capal, J. K. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s91248 · Cited by 20
Capal, J. K., Ritter, D. M., Franz, D. N., Griffith, M. S., Currans, K., Kent, B., Bebin, E. M., Northrup, H., Koenig, M. K., Mizuno, T., et al. (2024) · Annals of the Child Neurology Society · doi:10.1002/cns3.20070 · Cited by 20
Chiang, S., Moss, R., Meskis, M. A., Vogel‐Farley, V. K., Sullivan, J. E., Patel, A. D., & Rao, V. R. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108282 · Cited by 19
Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)?
Leclezio, L., Gardner‐Lubbe, S., & de Vries, P. J. (2018) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.12.006 · Cited by 19
Self-citationLiu, A. J., Staffaroni, A. M., Rojas-Martinez, J. C., Olney, N. T., Alquezar-Burillo, C., Ljubenkov, P. A., La Joie, R., Fong, J. C., Taylor, J., Karydas, A., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4284 · Cited by 18
Autism Spectrum Disorder and Epilepsy: Pathogenetic Mechanisms and Therapeutic Implications
Giliberti, A., Frisina, A. M., Giustiniano, S., Carbonaro, Y., Roccella, M., & Nardello, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072431 · Cited by 18
López‐Aranda, M. F., Chattopadhyay, I., Boxx, G. M., Fraley, E., Silva, T. K., Zhou, M., Phan, M., Herrera, I., Taloma, S. E., Mandanas, R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf2073 · Cited by 19
Samanta, D. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108577 · Cited by 19
Wang, Y., Pang, L.-Y., Ma, S., Zhang, M., Liu, L., & Zou, L. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.09.017 · Cited by 18
Kagitani‐Shimono, K., Kato, H., Soeda, F., Iwatani, Y., Mukai, M., Ogawa, K., Tominaga, K., Nabatame, S., & Taniike, M. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103288 · Cited by 17
Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
Müller, A. R., Luijten, M. A. J., Haverman, L., de Ranitz‐Greven, W. L., Janssens, P., Rietman, A. B., ten Hoopen, L. W., de Graaff, L. C. G., de Wit, M. Y., Jansen, A., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03012-4 · Cited by 17
Self-citationTowards an improved understanding of TSC-Associated Neuropsychiatric Disorders (TAND)
Leclezio, L., & de Vries, P. (2016) · Advances in Autism · doi:10.1108/aia-12-2015-0025 · Cited by 17
Self-citationAlperin, S., Krueger, D. A., Franz, D. N., Agricola, K. D., Stires, G., Horn, P. S., & Capal, J. K. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09408-8 · Cited by 17
Metadata
- Authors
- de Vries, P. J., Whittemore, V. H., Leclezio, L., Byars, A. W., Dunn, D., Ess, K. C., Hook, D., King, B. H., Sahin, M., & Jansen, A.
- Affiliations
- University of Cape Town (ZA)
- National Institutes of Health (US)
- Cincinnati Children's Hospital Medical Center (US)
- Riley Hospital for Children (US)
- Vanderbilt University Medical Center (US)
- Seattle Children's Hospital (US)
- Vrije Universiteit Brussel (BE)
- Corresponding author
- de Vries, Petrus J.
- Venue
- Pediatric Neurology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 52
- Issue
- 1
- Pages
- 25-35
- ISSN
- 0887-8994 (ISSN-L)
- PMC
- PMC4427347
- OpenAlex
- W2067318667
- Cited by
- 371
- References
- 41
- Citations by year
- 2026: 29 · 2025: 31 · 2024: 33 · 2023: 19 · 2022: 37 · 2021: 50 · 2020: 59 · 2019: 20 · 2018: 27 · 2017: 26 · 2016: 27 · 2015: 12
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Pediatric Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- NRF
- PERC
- Struengmann Fund
- NIH
- Novartis (1U01NS082320-01)
- Eli Lilly and Company
- Roche
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- tuberous sclerosis complex, neuropsychiatric disorders, treatment gap, intellectual disability, psychiatric comorbidity, psychosocial problems, terminology standardization
- MeSH terms
- Adolescent, Adult, Mental Disorders, Brain Diseases, Child, Child, Preschool, Humans, Infant, Terminology as Topic, Pilot Projects, Tuberous Sclerosis, Checklist
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
